Impedance-controlled bipolar radiofrequency ablation for menorrhagia

National Institute for Clinical Excellence
Record ID 32005000060
Authors' objectives:

This study aims to assess the current evidence on impedance-controlled bipolar radiofrequency ablation for menorrhagia.

Authors' recommendations: 1.1 Current evidence on the safety and efficacy of impedance-controlled bipolar radiofrequency ablation for menorrhagia appears adequate to support the use of this procedure, provided that the normal arrangements are in place for consent, audit and clinical governance. 1.2 Information is lacking about the long-term results of the procedure. Clinicians are encouraged to collect data on rates of recurrence and late complications, and they should ensure that patients are aware of the uncertainty about long-term safety and efficacy. Use of the Institute's Information for the Public is recommended. 1.3 It is recommended that the Medicines and Healthcare products Regulatory Agency (formally the Medical Devices Agency) safety notices on endometrial ablation are followed (MDA [1998] SN 9812 Devices used for endometrial ablation achieved by thermal means, and MDA [1999] SN 1999(18) Devices used for endometrial ablation, available from 1.4 Clinicians undertaking this procedure should have had adequate training. The British Society for Gynaecological Endoscopy has agreed to produce standards for training.
Authors' methods: Overview
Project Status: Completed
Year Published: 2004
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Catheter Ablation
  • Menorrhagia
  • Uterine Hemorrhage
Organisation Name: National Institute for Clinical Excellence
Contact Address: MidCity Place, 71 High Holborn, London WC1V 6NA, UK. Tel: +44 020 7067 5800; Fax: +44 020 7067 5801
Contact Name:
Contact Email:
Copyright: National Institute for Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.